Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pntd.0002188
Title: Sulfated Polysaccharide, Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of Dengue Virus Infection In Vitro: A Possible Candidate for Clinical Application
Authors: Ichiyama, K.
Gopala Reddy, S.B.
Zhang, L.F.
Chin, W.X.
Muschin, T.
Heinig, L.
Suzuki, Y.
Nanjundappa, H.
Yoshinaka, Y.
Ryo, A.
Nomura, N.
Ooi, E.E.
Vasudevan, S.G. 
Yoshida, T.
Yamamoto, N.
Issue Date: Apr-2013
Citation: Ichiyama, K., Gopala Reddy, S.B., Zhang, L.F., Chin, W.X., Muschin, T., Heinig, L., Suzuki, Y., Nanjundappa, H., Yoshinaka, Y., Ryo, A., Nomura, N., Ooi, E.E., Vasudevan, S.G., Yoshida, T., Yamamoto, N. (2013-04). Sulfated Polysaccharide, Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of Dengue Virus Infection In Vitro: A Possible Candidate for Clinical Application. PLoS Neglected Tropical Diseases 7 (4) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pntd.0002188
Abstract: Curdlan sulfate (CRDS), a sulfated 1→3-β-D glucan, previously shown to be a potent HIV entry inhibitor, is characterized in this study as a potent inhibitor of the Dengue virus (DENV). CRDS was identified by in silico blind docking studies to exhibit binding potential to the envelope (E) protein of the DENV. CRDS was shown to inhibit the DENV replication very efficiently in different cells in vitro. Minimal effective concentration of CRDS was as low as 0.1 μg/mL in LLC-MK2 cells, and toxicity was observed only at concentrations over 10 mg/mL. CRDS can also inhibit DENV-1, 3, and 4 efficiently. CRDS did not inhibit the replication of DENV subgenomic replicon. Time of addition experiments demonstrated that the compound not only inhibited viral infection at the host cell binding step, but also at an early post-attachment step of entry (membrane fusion). The direct binding of CRDS to DENV was suggested by an evident reduction in the viral titers after interaction of the virus with CRDS following an ultrafiltration device separation, as well as after virus adsorption to an alkyl CRDS-coated membrane filter. The electron microscopic features also showed that CRDS interacted directly with the viral envelope, and caused changes to the viral surface. CRDS also potently inhibited DENV infection in DC-SIGN expressing cells as well as the antibody-dependent enhancement of DENV-2 infection. Based on these data, a probable binding model of CRDS to DENV E protein was constructed by a flexible receptor and ligand docking study. The binding site of CRDS was predicted to be at the interface between domains II and III of E protein dimer, which is unique to this compound, and is apparently different from the β-OG binding site. Since CRDS has already been tested in humans without serious side effects, its clinical application can be considered. © 2013 Ichiyama et al.
Source Title: PLoS Neglected Tropical Diseases
URI: http://scholarbank.nus.edu.sg/handle/10635/110292
ISSN: 19352727
DOI: 10.1371/journal.pntd.0002188
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2013-sulfated_polysaccharide_curdlan_sulfate_efficiently-published.pdf7.13 MBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

33
checked on Mar 24, 2020

WEB OF SCIENCETM
Citations

30
checked on Mar 24, 2020

Page view(s)

124
checked on Mar 28, 2020

Download(s)

4
checked on Mar 28, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.